The Department of Veterans Affairs Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for the provision of hazardous sterile compounding services. The contract, valued at $2,433,675.00, has a period of performance through October 1, 2024 and was awarded without any set-aside designation, indicating it was a full and open commercial competition.
Under this IDC, the VA-VHA has issued several fixed-price delivery orders for Optum Pharmacy 801, Inc. to provide hazardous sterile compound products and services in support of VA healthcare programs, primarily serving the VA's Veterans Integrated Service Network 16 (VISN 16) region, with the majority of work performed at the contractor's facilities in Shreveport, Louisiana. The delivery orders range in value from $46,497.66 to $486,735.00 and cover option year exercises as well as base year performance. This contracting approach allows the VA-VHA to efficiently procure specialized pharmaceutical compounding services from Optum Pharmacy 801, Inc. as needed to support critical healthcare services for veterans.
Generated 1/23/25, 9:03 AM